v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Operating activities:    
Net loss $ (5,146) $ (2,164)
Adjustments to reconcile net loss to net cash used in operating activities:    
Amortization of deferred compensation 17
Stock-based compensation expense 3,211 1,149
Depreciation and amortization expense 325 307
Amortization of discount on convertible notes 715
Changes in fair value of derivative liabilities 278
Changes in operating assets and liabilities:    
Accounts receivable (100) (1,083)
Prepaids and other current assets (699) (192)
Other assets (7)
Accounts payable 612 (144)
Accrued expenses and other current liabilities 161 34
Net cash used in operating activities (1,643) (1,083)
Investing activities:    
Purchase of equipment (439) (85)
Net cash used in investing activities (439) (85)
Financing activities:    
Proceeds from stock option exercise 103 10
Proceeds from stock warrant exercise 690
Proceeds from convertible notes issuance 3,145
Proceeds from public offering, net of offering costs 23,385 12,587
Payment for taxes related to net share settlement of restricted stock units (56)
Net cash provided by financing activities 24,122 15,742
Net change in cash and cash equivalents, and certificate of deposit 22,040 14,574
Cash and cash equivalents, and certificate of deposit, beginning of period 15,740 1,291
Cash and cash equivalents, and certificate of deposit, end of period 37,780 15,865
Supplemental non-cash disclosures:    
Right of use asset - operating obtained in exchange for lease liability -operating 274
Conversion of convertible notes to stockholders’ equity 1,667
Conversion of derivative liabilities to stockholders’ equity $ 2,471

Source

PDF HTML
ZIP XBRL